About
François Nader, M.D., MBA is a veteran biopharma executive best known for serving as President, CEO, and Executive Director of NPS Pharmaceuticals, where he led the company through its growth and eventual sale to Shire. He has since held multiple board and chair roles across public and private life-sciences companies, including Moderna, BenevolentAI, Talaris, Acceleron, Tectonic Therapeutic, and GEn1E Lifesciences. His profile is strongest as an industry operator and board-level ecosystem influencer rather than a documented personal capital deployer.
Areas of interest
biotechrare diseasesinflammatory diseasesprecision medicineAI drug discoveryvaccinesmRNA therapeuticsdrug developmentregulatory strategycommercialization